161 related articles for article (PubMed ID: 748791)
1. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
2. Classification of the bladder cancer patient based on in vitro measurements of the immune response.
Lange PH; Hakala TR; Fraley EE
Cancer Res; 1977 Aug; 37(8 Pt 2):2885-90. PubMed ID: 326395
[TBL] [Abstract][Full Text] [Related]
3. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
Hakala TR
Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
[TBL] [Abstract][Full Text] [Related]
4. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
[No Abstract] [Full Text] [Related]
5. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
Jones LW; O'Toole C
Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
[TBL] [Abstract][Full Text] [Related]
6. [Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].
Mokhort VA; Grigorovich NA; Strotskiĭ AV; Mavrichev AS
Urol Nefrol (Mosk); 1986; (1):66-74. PubMed ID: 3513423
[No Abstract] [Full Text] [Related]
7. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
Troye M; Pape GR
Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
[TBL] [Abstract][Full Text] [Related]
9. Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment.
Antonaci S; Piccinno A; Lucivero G; Miglietta A; Piccininno A; Bonomo L
Tumori; 1981; 67(3):177-82. PubMed ID: 6974423
[No Abstract] [Full Text] [Related]
10. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
de Reijke TM; de Boer EC; Kurth KH; Schamhart DH
J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640
[TBL] [Abstract][Full Text] [Related]
11. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma.
Hermann GG
APMIS Suppl; 1993; 35():1-26. PubMed ID: 8251200
[No Abstract] [Full Text] [Related]
12. Carcinoma of the bladder.
Lamm DL
Tex Med; 1985 Feb; 81(2):32-4. PubMed ID: 3983864
[No Abstract] [Full Text] [Related]
13. In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
Cummings KB; Kodera Y; Bean MA
Natl Cancer Inst Monogr; 1978 Dec; (49):119-22. PubMed ID: 155220
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of the effect of BCG vaccine treatment in bladder tumour patients.
Kulcsár G; Nász I; Tenke P; Csata S
Acta Microbiol Hung; 1993; 40(2):151-7. PubMed ID: 8184669
[TBL] [Abstract][Full Text] [Related]
15. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
Sanchez-Carbayo M; Urrutia M; Romani R; Herrero M; Gonzalez de Buitrago JM; Navajo JA
Anticancer Res; 2001; 21(4B):3041-7. PubMed ID: 11712808
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
17. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
Flamm J; Grof F
Wien Med Wochenschr; 1981 Oct; 131(20):501-6. PubMed ID: 7314632
[TBL] [Abstract][Full Text] [Related]
18. Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer.
Mizutani Y; Nio Y; Fukumoto M; Yoshida O
Cancer; 1992 Jan; 69(2):537-45. PubMed ID: 1728384
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
Kaasinen ES; Harju LM; Timonen TT
J Urol; 2002 May; 167(5):2209-14. PubMed ID: 11956480
[TBL] [Abstract][Full Text] [Related]
20. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]